Exhaled particles and small airways

Respiratory Research

Volumn 20, Issue 1, 2019, Pages

  Bake, B ^a   Larsson, P ^a   Ljungkvist, G ^a   Ljungstrom E ^b   Olin, A C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Airway closure; Airway opening; Albumin; DPPC; Exhaled particles; POPC; Proteomics; Small airways; SP A; Surfactant

Indexed keywords

CALCIUM; CHLORIDE; PHOSPHOLIPID; POTASSIUM; BIOLOGICAL MARKER; LUNG SURFACTANT; SURFACTANT;

AEROSOL; AIRWAY DYNAMICS; AIRWAY OBSTRUCTION; ASTHMA; BREATHING; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; EPITHELIAL LINING FLUID; EXPIRATORY FLOW; EXPIRED AIR; HUMAN; HUMIDITY; PARTICLE SIZE; REVIEW; SMALL AIRWAY DISEASE; AIRWAY REMODELING; ANIMAL; BREATHING DISORDER; EXHALATION; METABOLISM; PHYSIOLOGY;

AIRWAY REMODELING; ANIMALS; BIOMARKERS; EXHALATION; HUMANS; PARTICLE SIZE; PULMONARY SURFACTANTS; RESPIRATION DISORDERS; SURFACE-ACTIVE AGENTS;

EID: 85059912682     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-019-0970-9     Document Type: Review

References (53)

1. Horvath I, Barnes PJ, Loukides S, Sterk PJ, Hogman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49.
2. Pecchiari M, Santus P, Radovanovic D, D'Angelo E. Acute effects of long-acting bronchodilators on small airways detected in COPD patients by single-breath N2 test and lung P-V curve. J Appl Physiol (1985). 2017;123:1266-75.
3. Santus P, Radovanovic D, Mascetti S, Pauletti A, Valenti V, Mantero M, Papi A, Contoli M. Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD. Pharmacol Res. 2018;133:160-9.
4. Konstantinidi EM, Lappas AS, Tzortzi AS, Behrakis PK. Exhaled breath condensate: technical and diagnostic aspects. ScientificWorldJournal. 2015;2015:435160.
5. Olofson JBB, Bergman B, Ullman A, Svärdsudd K. Prediction of COPD and related events improvs by combining spirometry and the single breath nitrogen test. COPD: J Chron Obstruct Pulmon Dis. 2018 In press.
6. Verbanck S. Physiological measurement of the small airways. Respiration. 2012;84:177-88.
7. Almstrand AC, Josefson M, Bredberg A, Lausmaa J, Sjovall P, Larsson P, Olin AC. TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls. Eur Respir J. 2012;39:59-66.
8. Almstrand AC, Ljungstrom E, Lausmaa J, Bake B, Sjovall P, Olin AC. Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Anal Chem. 2009;81:662-8.
9. Bredberg A, Gobom J, Almstrand AC, Larsson P, Blennow K, Olin AC, Mirgorodskaya E. Exhaled endogenous particles contain lung proteins. Clin Chem. 2012;58:431-40.
10. Larsson P, Bake B, Wallin A, Hammar O, Almstrand AC, Larstad M, Ljungstrom E, Mirgorodskaya E, Olin AC. The effect of exhalation flow on endogenous particle emission and phospholipid composition. Respir Physiol Neurobiol. 2017;243:39-46.
11. Ostling J, Van Geest M, Viklund E, Mirgorodskaya E, Olin A-C. Exploring particles from exhaled air as a new source for protein biomarkers from the airways. Eur Respir J 2017;50:Suppl 61, OA321.
12. Duguid JP. The numbers and the sites of origin of the droplets expelled during expiratory activities. Edinb Med J. 1945;52:385-401.
13. Loudon RG, Roberts RM. Droplet expulsion from the respiratory tract. Am Rev Respir Dis. 1967;95:435-42.
14. Papineni RS, Rosenthal FS. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med. 1997;10:105-16.
15. Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, Stone HA, Nardell E, Scheuch G. Inhaling to mitigate exhaled bioaerosols. Proc Natl Acad Sci U S A. 2004;101:17383-8.
16. Bake B, Ljungstrom E, Claesson A, Carlsen HK, Holm M, Olin AC. Exhaled particles after a standardized breathing maneuver. J Aerosol Med Pulm Drug Deliv. 2017;30:267-73.
17. Chao CYH, Wan MP, Morawska L, Johnson GR, Ristovski ZD, Hargreaves ZD, Mengersen K, Corbett S, Lif Y, Xie X, Katoshevski D. Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci. 2009;40:122-33.
18. Haslbeck K, Schwarz K, Hohlfeld JM, Seume JR, Koch W. Submicron droplet formation in the human lung. J Aerosol Sci. 2010;41:429-38.
19. Holmgren H, Ljungstrom E. Influence of film dimensions on film droplet formation. J Aerosol Med Pulm Drug Deliv. 2012;25:47-53.
20. Watanabe W, Thomas M, Clarke R, Klibanov AM, Langer R, Katstra J, Fuller GG, Griel LC, Fiegel J, Edwards D. Why inhaling salt water changes what we exhale. J Colloid Interface Sci. 2007;307:71-8.
21. Morawska LJGR, Ristowski ZD, Hargreaves M, Mengersen K, Corbett S, Chao CYH, Li Y, Katoshevski D. Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities. Aerosol Science. 2009;40:256-69.
22. Almstrand AC, Bake B, Ljungstrom E, Larsson P, Bredberg A, Mirgorodskaya E, Olin AC. Effect of airway opening on production of exhaled particles. J Appl Physiol (1985). 2010;108:584-8.
23. Johnson GR, Morawska L. The mechanism of breath aerosol formation. J Aerosol Med Pulm Drug Deliv. 2009;22:229-37.
24. Fabian P, Brain J, Houseman EA, Gern J, Milton DK. Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects. J Aerosol Med Pulm Drug Deliv. 2011;24:137-47.
25. Dollfuss RE, Milic-Emili T, Bates DV. Regional ventilation of the lung studied with boluses of 133 xenon. Resp Physiol. 1967;2.
26. Milic-Emili J, Henderson JA, Dolovich MB, Trop D, Kaneko K. Regional distribution of inspired gas in the lung. J Appl Physiol. 1966;21:749-59.
27. Sutherland PW, Katsura T, Milic-Emili J. Previous volume history of the lung and regional distribution of gas. J Appl Physiol. 1968;25:566-74.
28. Burger EJ Jr, Macklem P. Airway closure: demonstration by breathing 100 percent O2 at low lung volumes and by N2 washout. J Appl Physiol. 1968;25:139-48.
29. Engel LA, Grassino A, Anthonisen NR. Demonstration of airway closure in man. J Appl Physiol. 1975;38:1117-25.
30. Anthonisen NR, Danson J, Robertson PC, Ross WR. Airway closure as a function of age. Respir Physiol. 1969;8:58-65.
31. Hughes JM, Rosenzweig DY, Kivitz PB. Site of airway closure in excised dog lungs: histologic demonstration. J Appl Physiol. 1970;29:340-4.
32. Pecchiari M, Radovanovic D, Santus P, D'Angelo E. Airway occlusion assessed by single breath N2 test and lung P-V curve in healthy subjects and COPD patients. Respir Physiol Neurobiol. 2016;234:60-8.
33. Milic-Emili J, Torchio R, D'Angelo E. Closing volume: a reappraisal (1967-2007). Eur J Appl Physiol. 2007;99:567-83.
34. Holmgren H, Bake B, Olin AC, Ljungstrom E. Relation between humidity and size of exhaled particles. J Aerosol Med Pulm Drug Deliv. 2011;24:253-60.
35. Schwarz K, Biller H, Windt H, Koch W, Hohlfeld JM. Characterization of exhaled particles from the healthy human lung - a systematic analysis in relation to pulmonary function variables. J Aerosol Med Pulm Drug Deliv. 2010;23:371-9.
36. Holmgren H, Ljungström E, Almstrand A-C, Bake B, Olin A-C. Size Distribution of Exhaled Particles in the Range from 0.01 to 2.0 μm; 2010.
37. Johnson GR, Morawskaa L, Ristovski ZD, Hargreaves M, Mengersen K, Chao CYH, Wan MP, Li Y, Xie X, Katoshevski D, Corbett S. Modality of human expired aerosol size distributions. J Aerosol Science. 2011;42:839-51.
38. Holmgren H, Gerth E, Ljungstrom E, Larsson P, Almstrand AC, Bake B, Olin AC. Effects of breath holding at low and high lung volumes on amount of exhaled particles. Respir Physiol Neurobiol. 2013;185:228-34.
39. Schwarz K, Biller H, Windt H, Koch W, Hohlfeld JM. Characterization of exhaled particles from the human lungs in airway obstruction. J Aerosol Med Pulm Drug Deliv. 2015;28:52-8.
40. Larsson P, Mirgorodskaya E, Samuelsson L, Bake B, Almstrand AC, Bredberg A, Olin AC. Surfactant protein a and albumin in particles in exhaled air. Respir Med. 2012;106:197-204.
41. Larsson P, Larstad M, Bake B, Hammar O, Bredberg A, Almstrand AC, Mirgorodskaya E, Olin AC. Exhaled particles as markers of small airway inflammation in subjects with asthma. Clin Physiol Funct Imaging. 2017;37:489-97.
42. Beck O, Sandqvist S, Eriksen P, Franck J, Palmskog G. Method for determination of methadone in exhaled breath collected from subjects undergoing methadone maintenance treatment. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:2255-9.
43. Beck O, Sandqvist S, Franck J. Demonstration that methadone is being present in the exhaled breath aerosol fraction. J Pharm Biomed Anal. 2011;56:1024-8.
44. Ljungkvist Göran US, Åsa T, Karina S, Björn B, Per L, Ann-Charlotte A, Emilia V, Oscar H, Sören S, Olof B, Anna-Carin O. Two techniques to sample non-volatiles in breath - exemplified by methadone. J Breath Res. 2017; In press.
45. Larstad M, Almstrand AC, Larsson P, Bake B, Larsson S, Ljungstrom E, Mirgorodskaya E, Olin AC. Surfactant protein a in exhaled endogenous particles is decreased in chronic obstructive pulmonary disease (COPD) patients: a pilot study. PLoS One. 2015;10:e0144463.
46. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365:1567-75.
47. Nathan N, Taytard J, Duquesnoy P, Thouvenin G, Corvol H, Amselem S, Clement A. Surfactant protein a: a key player in lung homeostasis. Int J Biochem Cell Biol. 2016;81:151-5.
48. Enhorning G. Surfactant in airway disease. Chest. 2008;133:975-80.
49. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278:1355-60.
50. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-53.
51. Hogg JC, Pare PD, Hackett TL. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev. 2017;97:529-52.
52. Ericson PA, Mirgorodskaya E, Hammar OS, Viklund EA, Almstrand AR, Larsson PJ, Riise GC, Olin AC. Low levels of exhaled surfactant protein a associated with BOS after lung transplantation. Transplant Direct. 2016;2:e103.
53. Bredberg A, Josefson M, Almstrand AC, Lausmaa J, Sjovall P, Levinsson A, Larsson P, Olin AC. Comparison of exhaled endogenous particles from smokers and non-smokers using multivariate analysis. Respiration. 2013;86:135-42.